Department of Endocrine Disoders and Bone Metabolism, 1st Chair of Endocrinology, Medical University, Łódz, Poland.
Endokrynol Pol. 2011 Jan-Feb;62(1):38-44.
Steroid-induced osteoporosis is a textbook example of the secondary type of this medical condition. Glucocorticosteroids suppress bone formation by their direct and indirect effect on osteoblasts, osteoclasts and osteocytes, increasing their resorption and, eventually, leading to negative bone balance. A clinical problem arises regarding the fact that approximately 50% of patients on chronic steroid therapy undergo asymptomatic bone fractures. The treatment mode includes minimising the dose of administered steroids, encouraging an improved lifestyle and supplementation with adequate calcium and vitamin D3 doses. Bisphosphonates are a group of medical agents used both to prevent and treat steroid-induced osteoporosis, although new therapies have also become available in recent years.
激素诱导性骨质疏松症是这种医学病症的继发性类型的典型例子。糖皮质激素通过其对成骨细胞、破骨细胞和骨细胞的直接和间接作用抑制骨形成,增加其吸收,最终导致负性骨平衡。大约 50%接受慢性类固醇治疗的患者出现无症状性骨折,这一临床问题出现了。治疗模式包括减少给予的类固醇剂量、鼓励改善生活方式以及补充足够的钙和维生素 D3 剂量。双膦酸盐是一组用于预防和治疗激素诱导性骨质疏松症的药物,尽管近年来也出现了新的治疗方法。